Comment by
prophetoffactz on Feb 28, 2024 4:01pm
Gilles is in the best position to know the fairness of this deal given the partnering discussions around the diagnostic and PGX as well as his understanding of the pipelines. H.C. Wainwright issued a US$15 price target for AEZS before much of the recent biotech surge. C$100-C$150 million market cap target could be fair for both companies making it a merger of equals.